CD28 Targeted Co-Stimulatory Bispecific Antibodies for Treatment of Solid Tumors

• Discovery of CD28 agonists
• Indication specific development of CD28 targeted bispecific antibodies
• Development of a CD28xNectin-4 bispecific for bladder cancer treatment

Speakers:

Udaya Rangaswamy

Senior Director, Translational Biology

Rondo Therapeutics